Fraunhofer MEVIS among Winners of InnoHealth USA 2021

Fraunhofer MEVIS is among the winning teams of the call for Ideas & Innovation of the InnoHealth USA 2021 campaign. Nine Research-SME-Tandems and their innovative projects are invited to join the Matchmaking Tour USA and the Idea2Project Workshop.

©metamorworks - stock.adobe.com

The project Patho AI & Image Fusion represented by Fraunhofer MEVIS researcher Johannes Lotz and Felix Faber from MindPeak GmbH focuses on histological tissue-analysis using image fusion and AI technology. In this project, artificial intelligence (AI) is applied along with fusion of multiple images to correlate tissue structures and automate clinical diagnoses in histopathology. Image fusion allows faster and more precise training of AI models and can also be used to combine multiple stains. The tissue analysis software discriminates between tumor and non-tumor cells and finds regions of inflammatory cell infiltration and abnormal structures indicating cancer or other diseases.

InnoHealth USA is a campaign led by the Fraunhofer-Gesellschaft as part of the initiative Research in Germany funded by the Federal Ministry of Education and Research (BMBF). The campaign, adressing small and medium-sized enterprises (SME) and start-ups in the field of digital health, aims to connect the U.S. and German healthcare research sectors, to build networks and to identify areas for deeper collaboration for mutual benefit.

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …